---
title: "RENB.US (RENB.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/RENB.US/news.md"
symbol: "RENB.US"
name: "RENB.US"
parent: "https://longbridge.com/en/quote/RENB.US.md"
datetime: "2026-03-17T12:20:36.561Z"
locales:
  - [en](https://longbridge.com/en/quote/RENB.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RENB.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RENB.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/RENB.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/RENB.US/news.md)


# RENB.US (RENB.US) — Related News

### [Lunai Bioworks Inc. SEC 10-Q Report](https://longbridge.com/en/news/276164384.md)
*2026-02-17T20:21:01.000Z*
> Lunai Bioworks Inc. has released its latest Form 10-Q report, indicating improved financial performance with total opera

### [Delonix Bioworks clears IND for DX-104 vaccine in China & Australia for MenB; Feb 6, 2026.](https://longbridge.com/en/news/275127684.md)
*2026-02-06T12:33:17.000Z*
> In Shanghai on February 6, 2026, Delonix Bioworks shared news about their advancements in bacterial vaccine development.

### [Lunai Bioworks Unveils AI-Driven Platform to De-Risk Drug Discovery in Complex Diseases](https://longbridge.com/en/news/272454097.md)
*2026-01-13T20:17:39.000Z*
### [Lunai Bioworks Identifies Three Parkinson's Subtypes and Prioritized Drug Targets to Accelerate Proof-of-Concept Programs and Strategic Partnerships in a $13B Market | LNAI Stock News](https://longbridge.com/en/news/269087685.md)
*2025-12-09T04:45:00.000Z*
> Lunai Bioworks (NASDAQ: LNAI) has identified three Parkinson's disease subtypes and prioritized drug targets using its A

### [Lunai Bioworks discovers 3 Parkinson's subtypes, targets for $13B market. Exciting progress in precision therapeutics.](https://longbridge.com/en/news/269090661.md)
*2025-12-09T12:46:40.000Z*
> Today, in Sacramento, California, Lunai Bioworks (NASDAQ: LNAI), a biotechnology company utilizing AI to develop precisi